Here we go again. The FDA does not approve the Moderna booster because the increase from the second dose is too small by 0.5% of people (87.9 to 88.4).
That is wrong. Moderna penalized because their product is better in the first place?
Also, the most interesting case is the one SFDon and Scott C. agreed and Don did on his own, use a Moderna booster on top of the more common and weaker Pfizer! They say there is no data, so do that experiment and get the data. The intuition and precedent argues that diversity helps. Do you think the immune system reads the vials labels and says that part is not OEM! Do you insist on the same manufacturer for the yearly flu vaccines they push on you even when you do an oil change?
If you ask me it is politics, maybe combined with the fact that there is excess stock of Pfizer vaccines that will soon expire.
I shared my story of when I was unnecessarily vaccinated for Meningitis with expired vaccines because my country bought expired vaccines from another country? Deja vu all over again.
Some days I am so discouraged by the system that I think the virus is winning deservedly.
"Moderna said the mean antibody level of participants in its study was 1.8 times higher after the booster than it was after the second shot. In another measurement, the booster raised neutralizing antibodies at least fourfold in 87.9 percent of people compared to after the second dose, thus narrowly failing to meet the agency’s requirement of 88.4 percent."
